KCA
AMGN icon

Karn Couzens & Associates’s Amgen AMGN Stock Holding History

Karn Couzens & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$298K Sell
1,234
-70
-5% -$16.1K 0.19% 68
2021
Q4 		$293K Buy
+1,304
New +$275K 0.2% 65

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Karn Couzens & Associates's AMGN Position: Q1 2022 in Review

Karn Couzens & Associates reduced its Amgen (AMGN) stake by 5.4% in Q1 2022, selling an estimated $16.1K and leaving 1,234 shares worth $298K. The position accounts for 0.19% of the portfolio, ranked #68.

Karn Couzens & Associates first reported a position in AMGN in Q4 2021 and has held it in 2 quarters since. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Karn Couzens & Associates held 1,234 shares of Amgen worth $298K as of Q1 2022.
  • Karn Couzens & Associates sold 70 Amgen shares in Q1 2022, an estimated $16.1K.
  • Amgen made up 0.19% of Karn Couzens & Associates's portfolio in Q1 2022, its #68 holding.
  • Karn Couzens & Associates first reported a position in Amgen in Q4 2021 and has held it in 2 quarters since.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Karn Couzens & Associates's 13F filing for Q1 2022, filed 19 Apr 2022.